University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 14 of 18
Chronic Moderate Sleep Restriction in Older Adults
NCT01642719
Vilazodone for Treatment of Geriatric Depression
NCT01608295
Promoting Sleep and Healthy Aging Research Study (PRO-SHARE)
NCT01641263
Financial Incentives and Text Messaging to Improve African American Womens' Glycemic Control
NCT02384265
Combination Treatment for Augmenting Language in Children With ASD
NCT02574741
Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County
NCT02067507
Addressing Attitudes to Improve Use of Protective Headwear in Older Adults
NCT01582464
Anesthetic Techniques in EP Patients
NCT02664922
Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity
NCT01755962
Impact of Grape Consumption on Brain Metabolism and Cognitive Function
NCT01573611
Screening, Brief Intervention, and Referral to Treatment for Offenders
NCT01683643
Schema, Emotion, and Behavior Therapy for Children
NCT01784263
Web-Based Weight Management for Individuals With Mental Illness
NCT01324973
18-Month Study of Memory Effects of Curcumin
NCT01383161
Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora
NCT01861964
Varenicline for Methamphetamine Dependence
NCT01365819
Effect of Mindfulness Training on Sleep and Inflammation Among Older Adults With Sleep Problems
NCT01534338
Magnesium Supplementation in the Second Trimester of Pregnancy to Overweight and Obese Individuals
NCT01510665
eRT Remote Health Monitoring
NCT01495780
Equinox Personal Coaching Versus Self-Directed Exercise
NCT01778153
Schema, Emotion and Behavior-Based Therapy for School Children
NCT02010086
A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)
NCT01573949
Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
NCT01501084
Physician-Patient Communication Project
NCT01530867
Early Intervention for Youth at Risk for Bipolar Disorder
NCT01483391
Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
NCT01451736
Better Effectiveness After Transition - Heart Failure
NCT01360203
Pomegranate Extract and Memory
NCT01950221
Cocaine Use Reduction With Buprenorphine
NCT01402492
Home Electrocardiogram (ECG) Monitoring After Heart Transplantation
NCT01365806
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control
NCT01402453
Effects of Avocado When Added to a Meat Patty on Inflammation in Healthy Men
NCT01397071
Comparison of Markers of Kidney Function
NCT01403766
Centralized Off-Site Adherence Enhancement Program
NCT01409655
Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder
NCT01368510
Q-Trial in Patients With Hepatitis C
NCT01438320
Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)
NCT01388530
Pedaling Exercises for Disability and Activity Limitations
NCT01391949
Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor
NCT01519765
Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking
NCT01359709
Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
NCT01319045
Comparing Calories at Fast Food Restaurants
NCT01357434
Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125
Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood
NCT02634606
Inflammation-Induced Depressed Mood: The Role of Social Neurocognitive Mechanisms
NCT01671150
Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.
NCT01517516
Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
NCT01299961
Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection
NCT02597647
Quantitative Sensory Testing and Analysis of Post Inguinal Hernia Surgery Pain
NCT01534429
A Parenting and Self-Care Intervention for HIV Infected Mothers
NCT01586988
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.